Trials / Not Yet Recruiting
Not Yet RecruitingNCT06831617
AI-based Low Dose CBCT Reconstruction for Clinical Application
AI-based Low Dose CBCT Reconstruction for Lung Puncture Guidance: A Multicenter Randomized Controlled Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if AI-based low dose CBCT reconstructed images can guide lung puncture effectively. The main questions it aims to answer are: 1. Does the AI-based low dose CBCT reconstruction model reconstruct high quality images? 2. Is it possible that low-dose CBCT reconstructed images can guide lung puncture procedures without compromising the efficiency of the procedure? Researchers will compare AI-based low dose CBCT reconstructed images to a placebo (conventional CBCT images) to see if AI-based low dose CBCT reconstructed image can guide lung puncture procedures without compromising the efficiency of the procedure. Participants will: 1. Undergo lung puncture under AI-based low dose CBCT reconstructed images guidance or under conventional CBCT images 2. Be followed up for 1 week postoperative to obtain patient complications
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | AI-based low dose CBCT reconstructed images system | Participants in the experimental group undergo AI-based low dose (radiation dose is 1/6th of the dose used in the clinic) CBCT reconstructed images guided lung puncture procedures. |
| OTHER | Conventional CBCT images system | Participants in the experimental group undergo conventional CBCT images guided lung puncture procedures. |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2025-10-31
- Completion
- 2025-11-30
- First posted
- 2025-02-18
- Last updated
- 2025-02-18
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06831617. Inclusion in this directory is not an endorsement.